title: Anemia in chronic heart failure: can EPO reduce deaths?
abstract: Many patients with chronic heart failure also have anemia, an association that has been increasingly recognized in recent years. Whether treating anemia will improve outcomes in patients with heart failure has yet to be determined, however. The decision to use an agent to treat anemia in heart failure should be made on a case-by-case basis.
authors.affiliation: Division of Cardiovascular Medicine The Ohio State University, Columbus 43210-1252, USA. iyengar1@medctr.osu.edu
authors.forename: Srinivas
authors.initials: S
authors.lastname: Iyengar
authors.forename: William T
authors.initials: WT
authors.lastname: Abraham
mesh_terms: D000740:Anemia / Q000150:complications / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D006333:Heart Failure / Q000150:complications* / Q000401:mortality; D006801:Humans; D011994:Recombinant Proteins; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin